Navigation Links
American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/15/2010

oney">$0.14 per diluted share, reflecting an increase of approximately 40.0% compared to $0.10 per diluted share in the same period of 2008.

2009 Financial Performance

Revenue for the fiscal year 2009 increased 11.9% to $296.2 million from $264.6 million in 2008. During the same time period, gross profit decreased by 3.9% to $166.8 million from $173.6 million in the year 2008. Prescription pharmaceutical products generated revenue of $115.8 million, up 32.4% from $87.4 million in the year 2008, and OTC pharmaceutical products generated revenue of $128.4 million, down 6.6% from $137.5 million in 2008. The CCXA and Boke businesses contributed revenue of $34.9 million and $49.0 million, respectively, during the fiscal year 2009, compared with $24.8 million and $38.2 million in 2008. Revenue from CCXA and Boke increased by 40.8% and 28.2%, respectively, compared to the prior year, reflecting sustainable growth of the subsidiaries. Revenue from nutraceutical products increased 14.2% to $39.1 million from $34.3 million in the year before. Revenue from Nuo Hua's
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. American Society of Anesthesiologists: Is Apathy or Avarice Precluding Advocacy of Better Patient Safety?
2. Johnson & Johnson Consumer Companies, Inc., Unveils CYTOMIMIC(TM) Technology at 68th Annual Meeting of the American Academy of Dermatology
3. TEI Biosciences PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association
4. Air Filtration and Gas/Solid Separation Training by the American Filtration and Separations Society
5. Water Filtration and Liquid Separation Training by the American Filtration and Separations Society.
6. Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists
7. American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal
8. The American Society for Laser Medicine and Surgery Hosts Its 30th Annual Conference in Phoenix on April 14-18, 2010
9. DuPont Pledges Support to My American Farm Initiative
10. American Oriental Bioengineering Announces the Inclusion of 158 Drugs in Chinas National Insurance Catalog
11. Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON Manufacturing, Inc., ... of their 2nd generation cell therapy POD® design. The 2nd generation portfolio not ... represents a new POD® design. , “G-CON first offered our miniPOD CT ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has selected an optimized Erk inhibitor molecule for ... development of a new class of potential cancer ... a prime target for therapeutic intervention in cancer. ... survival benefits for B-Raf and Mek inhibitors. Erk ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... a Promising New Flavor Ingredient Achieves ... Collaboration Milestone, SAN ... ), a leading company focused on using proprietary,technologies to discover and ... announced today that it has,received a payment from The Coca-Cola Company ...
... Presentation at 48th ICAAC / IDSA 46th Annual ... Oct. 28 ,Medarex, Inc. (Nasdaq: MEDX ), ... PIP ), a biodefense company developing medical,countermeasures ... a pilot study showing that the anthrax anti-toxin, ...
... QUEBEC CITY, Oct. 28 /PRNewswire-FirstCall/ - AEterna Zentaris ... biopharmaceutical company focused on,endocrine therapy and oncology, today ... Officer, Paul Blake, MD, will present a company,overview ... on,Monday, November 3, 2008 at 8:00 am (Eastern ...
Cached Biology Technology:SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 2SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY 3Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 2Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 3Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 4Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 5Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 6Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R) 7
(Date:7/7/2015)... June 30, 2015 ... the addition of the "Capacitive Fingerprint Sensors ... To this date, fingerprint sensing technology is ... fingerprint sensors are well developed. This patent landscape ... The domain of capacitive fingerprint sensors ...
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2
... to as the land of opportunity. Faizan Naqvi, of ... NJIT gave him the opportunity, for instance, to work on ... the department of physics. Naqvi started the research when he ... helped him win a Goldwater Scholarship an award that ...
... cry for help with a device to diagnose dry eye, ... doesn,t produce enough tears or the tears evaporate too quickly. ... that controls the air around a patient,s eyes so doctors ... condition. Stephen Pflugfelder, the James and Margaret Elkins ...
... invertebrates living on the Port Valdez seafloor to stabilize ... scientist at the University of Alaska Fairbanks. "The ... the tsunami waves that followed, impacted every marine community ... assistant professor at the UAF School of Fisheries and ...
Cached Biology News:Third brother wins gold at NJIT 2Rice bioengineering students' invention may help diagnose painful eye condition 2Port Valdez invertebrates stabilized 26 years after quake 2
Mouse Axl MAb (Clone 175128)...
Mouse GDF-8 Propeptide Affinity Purified Polyclonal Ab...
... D. Dawbarn and S.J. Allen (1995) ... date reviews by world authorities on current ... for Alzheimer's disease. Several major advances have ... understanding of this disease. Topics include molecular ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
Biology Products: